BAFF plays an important role in the pathogenesis of various autoimmune diseases including systemic lupus erythematosus, and the anti-BAFF antibody belimumab has been approved as a treatment for systemic lupus erythematosus (Vincent et al., 2014). This evidence concerns the gene TNFSF13B and autoimmune disease.